ArticleResearch square2026
Retention in intensive adherence counselling as a pathway to viral suppression among virally non-suppressed adolescents and young people living with HIV in east-central Uganda: a sequential explanatory mixed-methods study.
Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Background: Intensive Adherence Counselling (IAC) is the recommended intervention for people living with HIV who experience virological non-suppression. However, evidence on retention across the IAC cascade and factors influencing sustained engagement among adolescents and young people living with HIV (AYPLHIV) remains limited. We assessed retention in IAC, its associated factors, and its relationship with viral load suppression among virally non-suppressed AYPLHIV in east-central Uganda. Methods: We conducted a sequential explanatory mixed-methods study across 32 public health facilities. Quantitative data were retrospectively extracted for 580 virally non-suppressed AYPLHIV aged 10-24 years enrolled in IAC between 2019 and 2024. Retention was defined as completion of all recommended IAC sessions. Modified Poisson regression with robust standard errors identified factors associated with retention. Twelve purposively selected participants, including AYPLHIV, caregivers, and healthcare providers, participated in in-depth interviews. Qualitative data were analysed using a deductive thematic approach guided by the Capability, Opportunity, Motivation-Behaviour framework. Results: Participants were predominantly female (62.8%) with a median age of 16.4 years (IQR: 12.9-21.2). Retention declined progressively across the IAC cascade from 100% at initiation to 86.7% at IAC-1, 71.2% at IAC-2, and 64.8% at IAC-3. Participants who completed all IAC sessions achieved significantly higher viral suppression than those who did not complete the cascade (p < 0.001). Retention was higher among participants receiving peer support (aPR = 1.35, 95% CI: 1.17-1.55), counsellor-led IAC (aPR = 2.80, 95% CI: 1.53-5.13), and those living within 5 km of a facility (aPR = 1.22, 95% CI: 1.01-1.49). Lower retention was associated with difficulty coping with HIV status, disruption of differentiated service delivery pathways, treatment supporter involvement and VHT support. Qualitative findings attributed disengagement to emotional distress, transport barriers, and substitution of formal counselling by family and community support systems. Conclusions: Retention in IAC among virally non-suppressed AYPLHIV was suboptimal and strongly associated with viral load suppression. Strengthening peer support, psychosocial care, counsellor-led services, and integration of IAC within differentiated HIV service delivery models may improve retention and treatment outcomes among AYPLHIV.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.